Psoriatic Arthritis and Psoriasis Treatment Decision Aid (DA)

University of Pennsylvania

Status: Active, not recruiting

Conditions: Psoriasis; Psoriatic Arthritis

Treatments: Other: Decision Aid

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT03737045

831515

Details and patient eligibility

About

The purpose of this study is to create and test a patient decision aid that facilitates the shared decision-making process when patients with psoriasis and/or psoriatic arthritis are starting or switching to a new therapy.

Full description

Prior to the interventional study, we will develop a decision aid using design thinking. In this interventional study, we will implement and test a patient-centered decision aid for therapy selection among patients with psoriasis and/or psoriatic arthritis who are starting or switching to a new medication.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age 18 years or older

2. Diagnosis of psoriasis (as confirmed by dermatologist) or psoriatic arthritis (as confirmed by rheumatologist)

3. Treated at Penn

   In addition to the above, for the observation and implementation phases of the study:

4. Initiation of a new psoriasis or psoriatic arthritis treatment

   • Biosimilars that have been approved by the FDA and available on the US market will similarly be eligible for participation
   • Patients may be taking other traditional DMARDs.
   • A washout period is not required.

Exclusion criteria

1. Unable to give informed consent

2. Youth, under the age of 18 years

3. Patients without psoriasis or psoriatic arthritis

4. Not being treated at a Penn clinic

   In addition to the above, for the observation and implementation phases of the study:

5. Not starting or switching to a new medication

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

Decision Aid Testing

Other group

Description:

Participants will have the opportunity to test the different decision aid prototypes while selecting new treatment/therapy.

Treatment:

Other: Decision Aid